¼¼°èÀÇ ´Ü¹éÁú °øÇÐ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¿¹Ãø : Á¦Ç° ¹× ¼­ºñ½º, ´Ü¹éÁú À¯Çü, ±â¼ú, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)
Protein Engineering Market Size, Share, Trends and Forecast by Product & Services, Protein Type, Technology, End User and Region, 2025-2033
»óǰÄÚµå : 1722832
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 134 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,130,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,507,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,884,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

´Ü¹éÁú °øÇÐ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 36¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ÀÌ ½ÃÀåÀÌ 2033³â±îÁö 82¾ï ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â 9.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÇöÀç ºÏ¹Ì°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, 2024³â¿¡´Â 40.6%¶ó´Â Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀΰøÁö´É(AI)À» ÅëÇÑ ÀÚµ¿È­´Â ´Ü¹éÁú ¸ðµ¨¸µ, ½Å¾à °³¹ß, »ê¾÷¿ë È¿¼Ò ÃÖÀûÈ­¸¦ °­È­ÇÏ¿© ´Ü¹éÁú °øÇÐ ½ÃÀå Á¡À¯À²À» È®´ëÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ ÀçÁ¤ Áö¿øÀº Çмú ¿¬±¸¸¦ Áö¿øÇÏ°í ´Ü¹éÁú Ä¡·áÁ¦ ¹× ÇÕ¼º »ý¹°ÇÐÀÇ Çõ½ÅÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

´Ü¹éÁú °øÇÐÀº ¿øÇÏ´Â °á°ú¸¦ ¾ò±â À§ÇØ ´Ü¹éÁú ¼­¿­À» °³¹ßÇϰųª º¯°æÇÏ´Â °úÁ¤À» ¸»ÇÕ´Ï´Ù. »õ·Î¿î ´Ü¹éÁúÀÇ ÇÕ¼ºÀ̳ª ±âÁ¸ ±¸Á¶³ª ¼­¿­ÀÇ º¯°æÀ» Æ÷ÇÔÇϸç, »õ·Î¿î ±â´É °­È­¸¦ À§ÇØ ¾Æ¹Ì³ë»ê ¼­¿­À» º¯°æÇÏ´Â ÀçÁ¶ÇÕ µ¥¿Á½Ã¸®º¸ÇÙ»ê(DNA) ±â¼úÀ» ÀÌ¿ëÇÕ´Ï´Ù. ÀÌ ±â¼úÀº »ê¾÷ÀûÀ¸·Î »ç¿ëµÇ´Â È¿¼Ò ¹× ´Ü¹éÁúÀÇ ´ë·® »ý»ê¿¡ ³Î¸® ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÃÖ±Ù ¿¬±¸ÀÚµéÀº ÀÇ·á, ¿¬±¸, »ê¾÷, °Ç°­, »ý¸í°øÇÐ ÀÀ¿ë ºÐ¾ß¿¡ ÀûÇÕÇÑ ´Ù¾çÇÑ ´Ü¹éÁúÀ» ¼³°èÇÏ´Â µ¥ ¼º°øÇÏ¿© Àü ¼¼°èÀûÀ¸·Î ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

´Ü¹éÁú °øÇÐ ½ÃÀå µ¿Çâ :

ÇÕ¼º »ý¹°Çп¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ´Ü¹éÁú ±â¹Ý ÀǾàǰ °³¹ß¿¡ ´ëÇÑ °ü½É Áõ°¡°¡ ½ÃÀå °³Ã´À» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´Ü¹éÁú ÀǾàǰÀÇ ÀÓ»ó °á°ú°¡ ¾çÈ£ÇÏ¿© ºñ´Ü¹éÁú ÀǾàǰ¿¡¼­ ´Ü¹éÁú Ä¡·áÁ¦·ÎÀÇ ÀüȯÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù. ÀÌ´Â ´Ü¹éÁú °áÇÌ ÁúȯÀÇ È®»ê°ú ÇÔ²² ´Ü¹éÁú °øÇп¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´Ü¹éÁú °øÇÐ ºÐ¾ßÀÇ ¿¬±¸ ¹× °³¹ß(R&D) Ȱµ¿¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡¿Í °°Àº ¿©·¯ Á¤ºÎÀÇ À¯¸®ÇÑ ÀÌ´Ï¼ÅÆ¼ºê°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçÁ¶ÇÕ ´ÜÀÏŬ·ÐÇ×ü(mAbs)ÀÇ ÃâÇö°ú ¾Ï ¹× ÀÚ°¡¸é¿ªÁúȯ°ú °°Àº ´Ù¾çÇÑ ÁúȯÀÇ Ä¡·á¿¡¼­ ´ÜÀÏŬ·ÐÇ×ü »ç¿ë·®ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¦Ç° äÅ÷üÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ó¾à ¾÷°è¿¡¼­´Â ÀÛ¹° ¼öÈ®·®À» ´Ã¸®°Å³ª ¹ÙÀÌ¿À¿¬·á »ý»êÀ» ÃËÁøÇϱâ À§ÇØ ±â´ÉÀ» °­È­ÇÑ È¿¼Ò¸¦ »ý»êÇϱâ À§ÇÑ ÀÀ¿ë ¿¬±¸°¡ ÁøÇàµÇ¾î ½ÃÀå ¼ºÀåÀÇ Ã˸ÅÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¹ÙÀÌ¿À½Ã¹Ð·¯ ¹× »ý¹°ÇÐÀû Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó °³¼±, ±â¼ú ¹ßÀü, Á¦Ç° Çõ½Å µî ´Ù¸¥ ¿äÀε鵵 ½ÃÀå Àü¸ÁÀ» ¹à°Ô Çϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ ´Ü¹éÁú °øÇÐ ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç° ¹× ¼­ºñ½ºº°

Á¦7Àå ½ÃÀå ºÐ¼® : ´Ü¹éÁú À¯Çüº°

Á¦8Àå ½ÃÀå ºÐ¼® : ±â¼úº°

Á¦9Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦11Àå SWOT ºÐ¼®

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå PorterÀÇ Five Forces ºÐ¼®

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global protein engineering market size was valued at USD 3.6 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 8.2 Billion by 2033, exhibiting a CAGR of 9.5% during 2025-2033. North America currently dominates the market, holding a significant market share of 40.6% in 2024. Artificial intelligence (AI-driven) automation enhances protein modeling, drug discovery, and industrial enzyme optimization, which is a key factor expanding the protein engineering market share. Government funding supports academic research, accelerating innovations in protein therapeutics and synthetic biology.

Protein engineering refers to the process of developing or changing a protein sequence to achieve the desired result. It involves the synthesis of new proteins or amendments in the existing structure or sequence and employs recombinant deoxyribonucleic acid (DNA) technology to alter amino acid sequences for novel and enhanced functions. It is widely utilized for the production of enzymes or proteins in large quantities for use in industrial settings. In recent years, researchers have successfully engineered a wide range of proteins tailored to medicine, research, industry, health, and biotechnology applications, which is escalating their demand across the globe.

Protein Engineering Market Trends:

The rising investments in synthetic biology and the improving focus toward protein-based drug development represent the primary factors driving the market growth. Additionally, there has been a significant shift toward protein therapeutics from non-protein drugs due to their associated positive clinical outcomes. This, in confluence with the widespread prevalence of protein-deficient diseases, is increasing the demand for protein engineering. Furthermore, several favorable initiatives undertaken by the government of various countries, such as increased funding for research and development (R&D) activities in the field of protein engineering, are propelling the market growth. Besides this, the advent of recombinant monoclonal antibodies (mAbs) and the increasing usage of monoclonal antibodies to treat various diseases, such as cancer and autoimmune diseases, are accelerating product adoption rates. Moreover, the ongoing research for applications of protein engineering in the agrochemical industry to generate enzymes with enhanced function to increase the crop yield or facilitate biofuel production is catalyzing the market growth. Other factors, including the escalating demand for personalized medicines, growing need for biosimilars and biologics, improving healthcare infrastructure, technological advancements, and product innovations, are also creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Product & Services:

Breakup by Protein Type:

Breakup by Technology:

Breakup by End User:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abzena Ltd., Agilent Technologies Inc., Amgen Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Codexis Inc., Danaher Corporation, Eli Lilly and Company, General Electric Company, Merck KGaA, Novo Nordisk A/S, PerkinElmer Inc., Thermo Fisher Scientific Inc. and Waters Corporation.

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Protein Engineering Market

6 Market Breakup by Product & Services

7 Market Breakup by Protein Type

8 Market Breakup by Technology

9 Market Breakup by End User

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â